Report Midlands Meeting 25 May 2011

A full 60 members came to the Midlands meeting on the 25th May to listen to Dr Ben Kennedy give a brilliant  talk on some of the latest thinking on CLL. Both new attendees and  the members  who are now regulars agreed that this was a thoroughly enjoyable meeting. The weather was fine, the venue was friendly, and we all had a great time even though we were meeting to discuss the illness that affects us all.

Report on the Brentford Meeting 19 September 2011

Our second autumn meeting at GSK house was attended by many enthusiastic people. Many thanks to GSK and especially to Philippa Manning who did the organisation at that end - it all went incredibly well.

It can be daunting to arrive at the headquarters of a global pharmaceutical company with the present level of security alerts in place- but the security people, and all the GSK staff,  were inevitable courteous, and we all got in to the meeting.

Report on the Oxford Members Meeting 16th March 2012

The Oxford members meeting was held on the 16th March 2012 at the Oxford Belfry Hotel.  We decided that this would be our largest meeting to date and were delighted to be able to accommodate 80 people at this event.

 The meeting began with an introduction and welcome from two of our Trustees, Chonette Taylor and Andrea Cockburn.  They then introduced some of our newer Trustees before commencing the discussion groups.

Report London Meeting 3 December 2013

The historic Great Hall at St Bartholomew’s Hospital, London, was the magnificent venue for the London meeting of the CLLSA. The meeting was well attended, filling the Hall, and with a good balance between recently diagnosed and pre and post treatment.

Presentations were made by:

Professor Daniel Catovsky is one of the original medical advisors to the CLL Support Association (CLLSA), which celebrates its 8th anniversary this year.

Report on the CLL Support Association Cardiff Meeting - 30th January 2013

It was good to see so many new and familiar faces on the day. Thank you to all who travelled some distance.

You are probably all aware of the changing landscape of CLL therapeutics. There is much to support the feelings of optimism as novel testing and treatments commence clinical trials. Much of the reason for this optimism was discussed at Cardiff.